Skip to main content
Top
Published in: Rheumatology International 6/2002

01-04-2002 | Original Article

Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis

Authors: Piercarlo Sarzi-Puttini, Marco Cazzola, Benedetta Panni, Maurizio Turiel, Tania Fiorini, Nebiat Belai-Beyene, Enrico Chèrié-Lignièré

Published in: Rheumatology International | Issue 6/2002

Login to get access
Metadata
Title
Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
Authors
Piercarlo Sarzi-Puttini
Marco Cazzola
Benedetta Panni
Maurizio Turiel
Tania Fiorini
Nebiat Belai-Beyene
Enrico Chèrié-Lignièré
Publication date
01-04-2002
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2002
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-001-0166-7

Other articles of this Issue 6/2002

Rheumatology International 6/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine